In the context of cancer, the type 2 cytokines IL-4, IL-5, IL-9, and IL-13 along with ILC2s, Th2, and Th9 cells may either promote or inhibit tumorigenesis in a context-dependent manner that involves complex interactions with cancer cells and the constituents of the tumour microenvironment. Here, IL9 is linked to neoplasm.